Abstract
Cancer cells are highly heterogeneous at the transcriptional level and epigenetic state. Methods to study epigenetic heterogeneity are limited in throughput and information obtained per cell. Here, we adapted cytometry by time-of-flight (CyTOF) to analyze a wide panel of histone modifications in primary tumor-derived lines of diffused intrinsic pontine glioma (DIPG). DIPG is a lethal glioma, driven by a histone H3 lysine 27 mutation (H3-K27M). We identified two epigenetically distinct subpopulations in DIPG, reflecting inherent heterogeneity in expression of the mutant histone. These two subpopulations are robust across tumor lines derived from different patients and show differential proliferation capacity and expression of stem cell and differentiation markers. Moreover, we demonstrate the use of these high-dimensional data to elucidate potential interactions between histone modifications and epigenetic alterations during the cell cycle. Our work establishes new concepts for the analysis of epigenetic heterogeneity in cancer that could be applied to diverse biological systems.
Original language | English |
---|---|
Pages (from-to) | 2696-2713 |
Number of pages | 18 |
Journal | Molecular Cell |
Volume | 82 |
Issue number | 14 |
Early online date | 17 Jun 2022 |
DOIs | |
Publication status | Published - 21 Jul 2022 |
Bibliographical note
Funding Information:We thank Y. Aylon and I. Tirosh for their important input. We are grateful to M. Monje for generously sharing with us the SU-DIPG48, SU-DIPG6, SU-DIPG6-GFP, SU-DIPG38, SU-DIPG25, and SU-DIPG13 cultures, and N. Jabado for her kind gift of the isogenic BT245 and SU-DIPG36 cultures. We thank S. Baker, L. Kasper, and the St. Jude Children's Research Hospital Pediatric Brain Tumor Portal, https://pbtp.stjude.cloud, for the SJ-HGGX39 cell line and the shK27M constructs. We thank C. Raanan, M. Zerbib, and I. Savchenko for their contribution in establishing the DIPG mouse model and G. Jona for his assistance with the lentivirus system. The graphical abstract and Figure 1A were created using biorender.com. Funding: E.S. is an incumbent of the Lisa and Jeffrey Aronin Family Career Development chair. This research was supported by grants from the European Research Council (ERC801655), the Israeli Science Foundation (1881/19), The German-Israeli Foundation for Scientific Research and Development, the Israeli Council for Higher Education (CHE) via the Weizmann Data Science Research Center, and Minerva. N.H. T.M. G.R. and E.S. designed the study, performed data analysis, and wrote the manuscript. N.H. T.M. and O.B. conducted the experiments. T.-M.S. assisted in CyTOF runs and panel design. N.F. and O.B. generated lentiviral expression systems. O.G. assisted with RNA sequencing. A.H. R.O. and L.F.-A. established the xenograft mice model and performed immunohistochemistry. S.A. J.G.M. and M.G.F. performed patients’ autopsy analysis. The authors declare no competing interests.
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Cell Biology